Total Payments
$6,090
2024 Payments
$65.58
Companies
43
Transactions
490
Medicare Patients
1,854
Medicare Billing
$246,341
Payment Breakdown by Category
Food & Beverage$5,950 (97.7%)
Other$75.46 (1.2%)
Education$52.00 (0.9%)
Travel$12.28 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,950 | 484 | 97.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75.46 | 4 | 1.2% |
| Education | $52.00 | 1 | 0.9% |
| Travel and Lodging | $12.28 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $816.59 | 90 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $753.95 | 100 | $0 (2019) |
| EMD Serono, Inc. | $657.41 | 45 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $475.22 | 37 | $0 (2019) |
| Allergan, Inc. | $440.98 | 34 | $0 (2020) |
| GENZYME CORPORATION | $436.44 | 25 | $0 (2020) |
| UCB, Inc. | $286.45 | 21 | $0 (2020) |
| Lundbeck LLC | $205.73 | 13 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $180.12 | 9 | $0 (2019) |
| ABBVIE INC. | $176.23 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.58 | 3 | Microtransponder, Inc. ($28.17) |
| 2023 | $21.18 | 1 | ABBVIE INC. ($21.18) |
| 2022 | $46.63 | 2 | ABBVIE INC. ($46.63) |
| 2020 | $733.73 | 47 | Biogen, Inc. ($169.71) |
| 2019 | $1,488 | 133 | Novartis Pharmaceuticals Corporation ($284.08) |
| 2018 | $2,027 | 175 | Avanir Pharmaceuticals, Inc. ($363.14) |
| 2017 | $1,708 | 129 | Biogen, Inc. ($242.78) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROLOGY | ||||||
| 05/03/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.17 | General |
| 04/11/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/16/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/02/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Neurology | ||||||
| 10/30/2020 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/07/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/28/2020 | GENZYME CORPORATION | LEMTRADA (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Neurology | ||||||
| 09/21/2020 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Neurology | ||||||
| 09/15/2020 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.46 | General |
| 08/21/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Neurology | ||||||
| 08/20/2020 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $28.67 | General |
| 08/13/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/10/2020 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $38.45 | General |
| 07/29/2020 | GENZYME CORPORATION | LEMTRADA (Biological), AUBAGIO | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neurology | ||||||
| 07/14/2020 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: NEUROLOGY | ||||||
| 06/29/2020 | GENZYME CORPORATION | LEMTRADA (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Neurology | ||||||
| 06/18/2020 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Immunology | ||||||
| 06/16/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Central Nervous System | ||||||
| 06/16/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 485 | 762 | $184,899 | $74,061 |
| 2022 | 5 | 505 | 777 | $164,132 | $68,759 |
| 2021 | 6 | 549 | 811 | $159,414 | $68,184 |
| 2020 | 5 | 315 | 537 | $90,319 | $35,336 |
Total Patients
1,854
Total Services
2,887
Medicare Billing
$246,341
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 225 | 474 | $99,930 | $44,092 | 44.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 139 | 143 | $38,480 | $14,643 | 38.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 22 | $12,144 | $3,720 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 27 | 27 | $8,937 | $2,836 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 22 | $7,854 | $2,488 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $7,002 | $2,471 | 35.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 32 | $4,480 | $1,963 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 24 | $6,072 | $1,848 | 30.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 226 | 485 | $91,227 | $38,812 | 42.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 179 | 183 | $45,545 | $19,259 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 42 | 42 | $12,465 | $4,347 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 28 | $7,422 | $3,246 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 39 | $7,473 | $3,096 | 41.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 123 | 270 | $50,490 | $22,138 | 43.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 187 | 193 | $47,749 | $20,806 | 43.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 114 | 200 | $26,000 | $11,333 | 43.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 74 | $14,060 | $5,929 | 42.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 55 | 55 | $16,213 | $5,738 | 35.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 17 | 19 | $4,902 | $2,240 | 45.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 139 | 335 | $46,565 | $19,593 | 42.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 69 | 69 | $18,354 | $7,542 | 41.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 90 | $18,360 | $6,223 | 33.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 30 | 31 | $5,084 | $1,456 | 28.6% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 12 | 12 | $1,956 | $520.89 | 26.6% |
About Dr. Shannon Kohake, MD
Dr. Shannon Kohake, MD is a Neurology healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063631380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shannon Kohake, MD has received a total of $6,090 in payments from pharmaceutical and medical device companies, with $65.58 received in 2024. These payments were reported across 490 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,950).
As a Medicare-enrolled provider, Kohake has provided services to 1,854 Medicare beneficiaries, totaling 2,887 services with total Medicare billing of $246,341. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location North Kansas City, MO
- Active Since 04/25/2007
- Last Updated 11/04/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1063631380
Products in Payments
- Rebif (Biological) $498.88
- NUEDEXTA (Drug) $423.38
- TYSABRI (Biological) $375.02
- ONZETRA Xsail (Drug) $330.57
- TECFIDERA (Drug) $321.24
- BOTOX (Biological) $314.76
- AUBAGIO (Drug) $208.03
- Briviact (Drug) $207.35
- ACTHAR (Biological) $180.12
- Gamunex-C (Biological) $176.19
- LEMTRADA (Drug) $163.72
- GILENYA (Drug) $142.66
- MAYZENT (Drug) $141.88
- NORTHERA (Drug) $137.77
- Mavenclad (Biological) $129.56
- Hizentra (Biological) $123.29
- APTIOM (Drug) $117.63
- Aimovig (Biological) $114.52
- NUPLAZID (Drug) $104.66
- BOTOX THERAPEUTIC (Biological) $92.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in North Kansas City
Dr. Steven Kosa, Md, MD
Neurology — Payments: $337,461
Neurology $337,461
Dr. John Eatman, M.d, M.D
Neurology — Payments: $80,380
Neurology $80,380
Larry Hollenbeck, Md, MD
Neurology — Payments: $15,794
Neurology $15,794
Dr. Cynthia Costa, Md, MD
Neurology — Payments: $9,988
Neurology $9,988
Fred Sachen, Md, MD
Neurology — Payments: $125.90
Neurology $125.90
Robert Satake, Md, MD
Neurology — Payments: $34.35
Neurology $34.35